Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMGEN INC Director's Dealing 2012

May 3, 2012

29819_dirs_2012-05-03_027505f0-14a3-4a85-b104-a48af77b0b05.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2012-05-03

Reporting Person: Harper Sean E (EVP, Research & Development)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-05-03 Common Stock M 6000 $42.13 Acquired 55840 Direct
2012-05-03 Common Stock M 8000 $50.44 Acquired 63840 Direct
2012-05-03 Common Stock F 4695 $71.17 Disposed 59145 Direct
2012-05-03 Common Stock F 6758 $71.17 Disposed 52387 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-05-03 Nqso (Right to Buy) $42.13 M 6000 Disposed 2015-04-29 Common Stock (6000) Direct
2012-05-03 Nqso (Right to Buy) $50.44 M 8000 Disposed 2016-04-28 Common Stock (8000) Direct

Footnotes

F1: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,125 RSUs which fully vest on 4/28/2013; 2,300 RSUs which vest in two equal annual installments of 1,150 each commencing 4/26/2013; 25,000 RSUs which fully vest on 12/31/2014; 6,000 RSUs which vest in two equal installments of 1,980 each on 4/25/2013 and 4/25/2014 and one installment of 2,040 on 4/25/2015; and 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.